Attention-Deficit/Hyperactivity Disorder in Children and Adolescents With Obsessive-Compulsive Disorder: Fact or Artifact?

DANIEL A. GELLER1, JOSEPH BIEDERMAN1, STEPHEN V. FARAONE1, KATHLEEN CRADOCK1, LISA HAGERMOSER1, NOREEN ZAMAN1, JEAN A. FRAZIER1, BARBARA J. COFFEY1, THOMAS J. SPENCER1
1Dr. Geller is Director of the Obsessive Compulsive Disorder Clinic, McLean Hospital, and Assistant Professor of Psychiatry, Harvard Medical School, Boston. Professor Biederman is Chief of the Joint Program in Pediatric Psychopharmacology, Massachusetts General and McLean Hospitals, Boston. Drs. Faraone, Spencer, Coffey, and Frazier and Ms. Cradock, Ms. Hagermoser, and Ms. Zaman are with the Pediatric Psychopharmacology Clinic, Boston

Tài liệu tham khảo

American Psychiatric Association, 1994 Angold, 1993, Depressive comorbidity in children and adolescents: empirical, theoretical, and methodological issues, Am J Psychiatry, 150, 1779, 10.1176/ajp.150.12.1779 Biederman, 1993, Diagnoses of attention-deficit hyperactivity disorder from parental reports predict diagnoses based on teacher reports, J Am Acad Child Adolesc Psychiatry, 32, 315, 10.1097/00004583-199303000-00011 Biederman, 1990, Parent-based diagnosis of attention deficit disorder predicts a diagnosis based on teacher report, J Am Acad Child Adolesc Psychiatry, 29, 698, 10.1097/00004583-199009000-00004 DeVeaugh-Geiss, 1992, Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder: a multicenter trial, J Am Acad Child Adolesc Psychiatry, 31, 45, 10.1097/00004583-199201000-00008 Flament, 1985, Clomipramine treatment of childhood obsessive-compulsive disorder: a double-blind controlled study, Arch Gen Psychiatry, 42, 977, 10.1001/archpsyc.1985.01790330057007 Geller, 2001, Developmental aspects of obsessive compulsive disorder: findings in children, adolescents, and adults, J Nerv Ment Dis, 189, 471, 10.1097/00005053-200107000-00009 Geller, 2001, Disentangling chronological age from age of onset in children and adolescents with obsessive-compulsive disorder, Int J Neuropsychopharmacol, 4, 169, 10.1017/S1461145701002395 Geller, 1996, Comorbidity of juvenile obsessive-compulsive disorder with disruptive behavior disorders, J Am Acad Child Adolesc Psychiatry, 35, 1637, 10.1097/00004583-199612000-00016 Geller, 1995, Similarities in response to fluoxetine in the treatment of children and adolescents with obsessive-compulsive disorder, J Am Acad Child Adolesc Psychiatry, 34, 36, 10.1097/00004583-199501000-00011 Hanna, 1995, Demographic and clinical features of obsessive-compulsive disorder in children and adolescents, J Am Acad Child Adolesc Psychiatry, 34, 19, 10.1097/00004583-199501000-00009 Hollingshead, 1975 King, 1991, Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment, J Am Acad Child Adolesc Psychiatry, 30, 179, 10.1097/00004583-199103000-00003 Lahey, 1994, DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents, Am J Psychiatry, 151, 1673, 10.1176/ajp.151.11.1673 Leckman, 1982, Best estimate of lifetime psychiatric diagnosis: a methodological study, Arch Gen Psychiatry, 39, 879, 10.1001/archpsyc.1982.04290080001001 Leonard, 1989, Treatment of obsessivecompulsive disorder with clomipramine and desipramine in children and adolescents, Arch Gen Psychiatry, 46, 1088, 10.1001/archpsyc.1989.01810120030006 Leonard, 1991, A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder, Arch Gen Psychiatry, 48, 922, 10.1001/archpsyc.1991.01810340054007 March, 1995, Cognitive-behavioral psychotherapy for children and adolescents with OCD: a review and recommendations for treatment, J Am Acad Child Adolesc Psychiatry, 34, 7, 10.1097/00004583-199501000-00008 March, 1998, Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized control trial, JAMA, 280, 1752, 10.1001/jama.280.20.1752 March, 1997, The Expert Consensus Guideline Series: treatment of obsessive-compulsive disorder, J Clin Psychiatry, 58, 5 Orvaschel, 1994 Riddle M, Claghorn J, Gaffney G et al. (1996), Fluvoxamine for OCD in children and adolescents: a controlled trial. In: Scientific Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry pp 110–111 Riddle, 1992, Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive, J Am Acad Child Adolesc Psychiatry, 31, 1062, 10.1097/00004583-199211000-00011 Riddle, 1990, Obsessive compulsive disorder in children and adolescents: phenomenology and family history, J Am Acad Child Adolesc Psychiatry, 29, 766, 10.1097/00004583-199009000-00015 Rosenberg, 1999, Paroxetine open-label treatment of pediatric outpatients with obsessive-compulsive, J Am Acad Child Adolesc Psychiatry, 38, 1180, 10.1097/00004583-199909000-00024 Swedo, 1989, Obsessive-compulsive disorder in children and adolescents: clinical phenomenology of 70 consecutive cases, Arch Gen Psychiatry, 46, 335, 10.1001/archpsyc.1989.01810040041007 Thomsen, 1997, Child and adolescent obsessive-compulsive disorder treated with citalopram: findings from an open trial of 23 cases, J Child Adolesc Psychopharmacol, 7, 157, 10.1089/cap.1997.7.157